alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.8


Named Executive Officer Salary and Bonus Arrangements for 2005


       Base Salaries


       The base salaries for 2005 for the executive officers (the "named executive officers") of
Great Southern Bancorp, Inc. (the "Company") and Great Southern Bank (the "Bank") who will
be named in the compensation table that will appear in the Company's upcoming 2005 annual
meeting proxy statement are as follows:


	Name and Title		Base Salary
	 
	William V. Turner
Chairman of the Board of

 the Company and the Bank	$200,000(1)
	 
	Joseph W. Turner
President and Chief
 Executive Officer of the 
 Company and the Bank	$215,000 
	 
	Rex A. Copeland
Treasurer of the Company
 and Senior Vice President and
 Chief Financial Officer of the Bank	$160,000
	 
	Steven G. Mitchem
Senior Vice President and Chief
 Lending Officer of the Bank	$160,000




______________

(1) During 2005, William V. Turner will also receive payments of salary previously deferred totaling approximately
$25,000.


       Description of Bonus Arrangements


       In conjunction with the increase in his base annual salary from $188,000 to $200,000,
William V. Turner waived his right to receive the annual cash bonus provided for in his
employment agreement (one-half of one percent of the Company's pre-tax net income); these
changes will result in his 2005 compensation being approximately $187,000 less than his 2004
compensation.  For 2005, the annual cash bonus payable to Joseph W. Turner under his
employment agreement was increased from one-half of one percent of the Company's pre-tax net
income to three-fourths of one percent of the Company's pre-tax net income.  For 2005, as for
2004, each of Messrs. Copeland and Mitchem, along with the other executive officers of the
Company and the Bank, will be eligible for a cash bonus of up to 15% of base annual salary, with
one half of this possible bonus payable if the Company achieves targeted growth in earnings per
share for 2005 and one-half of the possible bonus awarded based on individual performance in
2005.  For 2005, as for 2004, in addition to the bonus to which he is entitled under his
employment agreement, Joseph W. Turner will again be eligible for a discretionary bonus for
individual performance.
##### 



EXHIBIT 12.2 RULE 13A-14(A) CERTIFICATION IN ACCORDANCE WITH
SECTION 302 OF THE SARBANES OXLEY ACT OF 2002 I, Edward D. Ford, Director and acting Chief Accounting Officer of International Gemini Technology
Inc. (the Company), certify that: 
 1. I have reviewed this
annual report on Form 20-F/A of the Company; 
 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or
omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this
report; 3. Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of operations
and cash flows of the Company as of, and for, the periods presented in this report; 4. The Companys other certifying officer and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for
the Company and have: a) Designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information relating to
the Company, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared; b) Evaluated the effectiveness of the Companys disclosure controls and procedures and presented in
this report our conclusions about the effectiveness of the disclosure controls and procedures, as
of the end of the period covered by this report based on such evaluation; and c) Disclosed in this report any change in the Companys internal control over financial reporting
that occurred during the period covered by the annual report that has materially affected, or is
reasonably likely to materially affect, the Companys internal control over financial reporting;
and 5. The Companys other certifying officer and I have disclosed, based on our most recent evaluation
of internal control over financial reporting, to the Companys auditors and the audit committee of
the Companys board of directors (or persons performing the equivalent functions): a) All significant deficiencies and material weaknesses in the design or operation of internal
control over financial reporting which are reasonably likely to adversely affect the Companys
ability to record, process, summarize and report financial information; and b) Any fraud, whether or not material, that involves management or other employees who have a
significant role in the Companys internal control over financial reporting. 
 Date: September 22, 2005 
 /s/ Edward D. FordEdward D. FordDirector and acting Chief Accounting Officer
Director Compensation Schedule



 Exhibit 10.1 
  
 Director Compensation Schedule 
  
 Board of Directors 
  
 Per Meeting Compensation 
  
 $7,500 per regular quarterly meeting attended in person (for all directors) 
  
 $2,500 per regular quarterly meeting (in lieu of above amount) for telephonic participation (for all directors) 
  
 $750 per meeting attended in person or via telephone for all meetings in addition to regular
quarterly meetings (for all Board members) 
  
 Committee Chairs 

 
 Quarterly Retainers 
  
 $4,000 to Audit Committee Chairperson 
  
 $2,500 to Compensation Committee Chairperson 
  
 $2,500 to Nominating & Governance Committee Chairperson 
  
 Committee Meeting Fees 
  
 $750 per Audit Committee meeting attended in person or via telephone, with no cap on number of meetings (for all committee members) 
  
 $750 per Compensation Committee or Nominating & Governance Committee Meeting attended in person or via telephone, with cap of 3 meetings
per quarter (for all committee members) 
  

 None of the above-referenced compensation shall be paid to any members of the Board of Directors (or committees thereof) who is also an employee of the Company.
<PAGE>
                                                                   EXHIBIT 10.10


                                  ADDENDUM TO LEASE AGREEMENT NO. BMA-D-1/99-001

AGREEMENT ENTERED BY AND (SIC) BAJA DEL MAR, S.A. DE C.V. REPRESENTED BY UC.
FRANCISCO RUBIO CARDENAS, IN HIS CAPACITY AS LEGAL REPRESENTATIVE HEREINAFTER
REFERRED TO AS THE "LANDLORD", AND ON THE OTHER HAND BLOCK MEDICAL DE MEXICO,
S.A. DE C.V. REPRESENTED BY MR. PABLO ANGEL QUINTANA, IN HIS CAPACITY AS LEGAL
REPRESENTATIVE HEREINAFTER REFERRED TO AS THE "TENANT"; IN ACCORDANCE WITH THE
FOLLOWING STATEMENTS AND CLAUSES:

                              S T A T E M E N T S:

1. Both parties agree that on November 30, 1999, they entered into a Lease
   Agreement No. BMA-D-1-99-001 on an industrial building identified as D-1,
   with a total area of 25,738 square feet.

2. In this act, both parties agree to modify the contents of this lease in
   reference to Clause Second & Clause Third. Except as set forth below,
   all other provisions of the Lease will continue in full force and
   effect.

                                 C L A U S E S:

1. CLAUSE SECOND "TERM": is hereby modified in this act to aloud (sic) the
   "Tenant" to lease building D-1 starting January 1st, 2005 and ending
   December 31, 2008, with 2 (two) renewal options of 4 (four) years each.

2. CLAUSE THIRD "RENT": is hereby modified to $11,067.34 Dollars (Eleven
   thousand sixty seven dollars and 34/100 USCY) effective as of January 1st,
   2005, payable in Mexican Currency at the exchange rate published by Central
   Bank of Mexico on the payment date of the rent.

   All other Declarations and Clauses of contract No. BMA-D-1-99-001 remain in
   force and in conformity with its terms.

   After reading the contents of this Addendum of Agreement, both parties
   signed in conformity in the presence of witnesses, on December 2nd, 2004,
   Tijuana, Baja California, MX.

   THE "LANDORD"                                                  THE "TENANT"


   BAJA DEL MAR, S.A. DE C.V.            BLOCK MEDICAL DE MEXICO, S.A. DE C.V.


   /s/ Llc. Francisco Rubio Cardenas             /s/ Mr. Pablo Angel Quintana
   ----------------------------------            -----------------------------
   Llc. Francisco Rubio Cardenas                   Mr. Pablo Angel Quintana
   Legal representative                              Legal Representative


                                    GUARANTOR
                               I-FLOW CORPORATION

                            /s/ Mr. James Dal Porto
                            -----------------------
                              Mr. James Dal Porto


   WITNESS                                                             WITNESS
EXCEPTIONALEVENTREQUESTSBYREGION,2011-2013Region10-276-----------/Region6-279Region7-58Region8- 1,993)ource:USEPA'sAirQlllalitySystems(AQS)database(March27,2015).NumbersshownareasumofdaysflaggedinAQSatmonitorswithinheregion,fromJanuaty1,2011toDecember31,2013.Numbersincludeconcunedandnon-concurredeventflags.Regions1and2hadnoeventrequestsduring2011-2013.AIR1500034.xlsx
Exhibit 32.2  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002   In connection with the Report of Castle Arch Real Estate Investment Company, L.L.C. a California limited liability company (the Company) on Form 10-QSB for the period ending June 30, 2007 as filed with the Securities and Exchange Commission (the Report) I,   Douglas W. Child, Chief Financial Officer (Principal Financial Officer) hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to my knowledge:  a. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and  b. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.   /s/ Douglas W. Child Douglas W. Child, Chief Financial Officer (Principal Financial Officer)  Dated August 13, 2007
Home
|
Archives

| Historical Materials in        the John F. Kennedy Library |
|------------------------------------------------------------|

**Introduction
Archives and        Manuscripts (149K)
Audio Visual Archives
Oral History        (218K)
Motion Picture        Archives
Presidential        Recordings
Printed Materials
Sound Recordings
Still Photographs
Index
Download        Historical Materials in the JFK Library (Compressed HTML file, 230K)

**Research      Room**

**Inaugural      Address**

**Berlin      Speech****John Fitzgerald Kennedy Library -        Columbia Point - Boston, Massachusetts 02125**Tel: 1-877-616-4599        Fax: 617-929-4538**Email:**library@kennedy.nara.gov
**John Fitzgerald        Kennedy Library Foundation - Columbia Point - Boston, Massachusetts        02125**Tel: 617-929-1200        Fax: 617-436-3395**Email:**foundation@kennedy.nara.gov

**Visit**NARA

Please note        that any communications received by the Kennedy Library via electronic        mail may become part of the permanent record of the library. All        communications with the library are subject to the provisions of the        Privacy Act. See our Privacy Statement. Terms        of use for this site are the same as those for using any National        Archives Web site.

**Page      created June 18, 1996 updated: February 19, 2001**
 Home| Archives| Topof Page |

**
Exhibit
      32.2








CERTIFICATION
      PURSUANT TO


SECTION
      1350, CHAPTER 63 OF TITLE 18, UNTIED STATES CODE,


as
      adopted pursuant to


SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002





In
      connection with
      the annual report of Theragenics Corporation (the “Company”) on Form 10-K for
      the fiscal year ended December 31, 2006, as filed with the Securities and
      Exchange Commission on the date hereof (the “Report”), I, Francis J. Tarallo,
      Chief Financial Officer, certify pursuant to 18 U.S.C. Section 1350, as adopted
      pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





(1) the
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and




(2) the
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company as of the
      dates
      and for the periods referred to in the Report.





Date:
      March 8, 2007





/s/
      Francis J. Tarallo


Francis
      J. Tarallo


Chief
      Financial Officer
Exhibit
32.1





Certification of Principal
Executive Officer


Pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to


Section
906 of the Sarbanes-Oxley Act of 2002





In connection with the Quarterly Report
of SRKP 2, Inc. (the "Company") on Form 10-Q for the period ending September 30,
2010 as filed with the Securities and Exchange Commission on the date hereof
(the "Report"), I, Richard A. Rappaport, certify, pursuant to 18 U.S.C. ss.
1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that to
my knowledge:





(1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





/s/ Richard A. RappaportRichard
      A. RappaportPrincipal
      Executive OfficerNovember
      9, 2010
<PAGE>   1


                                   EXHIBIT 21

                              LIST OF SUBSIDIARIES


Capstone Med., Inc. f/k/a DCMED, Inc.

MediDyne Corp.

PharMerica Drug Systems, Inc.

DOC Pharmacy, Inc.

Hollins Manor I, LLC.

Goot's Goodies, Inc.

Southwest Pharmacies, Inc.

Goot Westbridge Pharmacy, Inc.

Goot Nursing Home Pharmacy, Inc.

Goot's Pharmacy and Orthopedic Supply, Inc.

Capstone Pharmacy of Delaware, Inc.
  f/k/a B.T. Smith, Inc.

Rombro's Drug Center, Inc.

Family Center Pharmacy, Inc.

Compuscript, Inc.

Premier Pharmacy, Inc.

Pharmacy Corporation of America

Tmesys, Inc.

Express Pharmacy Services, Inc.

Alliance Health Services, Inc.

Beverly Acquisition Corporation

Computran Systems, Inc.

Dunnington Drug, Inc.



<PAGE>   2

Healthcare Prescription Services, Inc.

Insta-Care Holdings, Inc.

Medical Health Industries, Inc.

Alliance Home Health Care, Inc.

Brownstone Pharmacy, Inc.

Omni Med B, Inc.

Dunnington Rx Services of Rhode Island, Inc.

Dunnington Rx Services of Massachusetts, Inc.

DD Wholesale, Inc.

Pharmacy Corporation of America-Massachusetts, Inc.

Insta-Care Pharmacy Services Corporation

Pharmacy Dynamics Group, Inc.
#### § 29.2258 Color intensity.

The varying degree of saturation or chroma. Color intensity as applied to tobacco describes the strength or weakness of a specific color or hue. It is applicable to brown colors. (See chart, § 29.2351.)
#### §§ 1735.4-1735.9 [Reserved]
[Federal Register Volume 75, Number 218 (Friday, November 12, 2010)]
[Notices]
[Page 69461]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-28523]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated June 17, 2010, and published in the Federal 
Register on June 28, 2010 (75 FR 36684), Cerilliant Corporation, 811 
Paloma Drive, Suite A, Round Rock, Texas 78665-2402, made application 
by letter to the Drug Enforcement Administration (DEA) to be registered 
as an importer of the basic classes of controlled substances listed in 
schedule I:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Racemoramide (9645)........................  I
Tilidine (9750)............................  I
------------------------------------------------------------------------

    The company plans to import small quantities of the listed 
controlled substances for the manufacture of analytical reference 
standards.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the 
registration of Cerilliant Corporation to import the basic classes of 
controlled substances is consistent with the public interest, and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. DEA has investigated Cerilliant 
Corporation to ensure that the company's registration is consistent 
with the public interest. The investigation has included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 
952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above 
named company is granted registration as an importer of the basic class 
of controlled substance listed.

    Dated: November 1, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-28523 Filed 11-10-10; 8:45 am]
BILLING CODE 4410-09-P
#### § 29.405 Inspection by submitted samples.

The Director, in lieu of onsite inspection, may approve submission by the importer of samples where time, geographical distance, or availability of inspectors prevent a timely onsite inspection, or where tobacco is classified as a “temporary importation under bond” as defined in 19 CFR 10.31 *et seq.* The importer shall certify that sampling was conducted in accordance with procedures approved by the Director. All tobacco inspected by submitted sample is subject to spot-checking at the discretion of the Director. Submitted samples shall be disposed of in a manner approved by the Director unless return of the sample is requested by the importer at the time of submission. Samples will only be returned at the importer's expense.

[49 FR 27468, July 13, 1984]
<PAGE>


EXHIBIT 23.2

CONSENT OF INDEPENDENT ACCOUNTANTS


We hereby consent to the incorporation by reference in the Prospectus
constituting part of the Registration Statement on Form S-2 (No. 33-63785), the
Registration Statements on Form S-3 (No. 333-77907, No. 333-74625, No. 33-03761,
No. 33-38723, and No. 33-44133) and the Registration Statements on Form S-8 (No.
333-77861, No. 33-8933, No. 33-14529, No. 33-30218, No. 33-59794, No. 33-13249,
No. 33-30219, No. 33-40663, No. 33-69066, No. 33-30220, No. 33-69068, No.
33-61051, No. 33-38099, No. 33-80864, No. 33-84214, No. 33-38701, and No.
33-56145) of Interleaf, Inc. of our report dated May 6, 1999 relating to the
financial statements and financial statement schedule, which appears in this
Form 10-K.


PricewaterhouseCoopers LLP

Boston, Massachusetts
June 29, 1999
Exhibit 32.1


                          Section 1350 Certification
                           -------------------------

           The following statement is provided by the undersigned to accompany
the Form 10-K of The Willowbridge Fund, L.P. pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).

           The undersigned certifies that the foregoing Report on Form 10-K
fully complies with the requirements of Section 13(a) of the Securities
Exchange Act of 1934 (15 U.S.C. 78m) and that the information contained in the
Form 10-K fairly presents, in all material respects, the financial condition
and results of operations of The Willowbridge Fund, L.P.


March 18, 2005


/s/ Robert L. Lerner
-----------------------------
Robert L. Lerner
President
Ruvane Investment Corporation,
the general partner of
The Willowbridge Fund, L.P.
98-1274.

#### Laidlaw Waste Sys., Inc. v. Consol. Rail Corp.

Certified State Law Question, No. C2980227. On review of preliminary memoranda pursuant to S.Ct.Prac.R. XVIII(6). The court will answer the following question found at page 3 of the Certification Order of the United States District Court for the Southern District of Ohio, Eastern Division:

“What is the effective date of Ohio Revised Code § 4123.93, as enacted by Am.Sub.H.B. No. 107, following the April 8,1994 order issued in *State ex rel. Ohio AFL-CIO v. Voinovich,*69 Ohio St.3d 225*1418[631 N.E.2d 582] (1994), and the April 29, 1994 order issued in *State ex rel. Ohio AFL-CIO v. Voinovich,*69 Ohio St.3d 1208 [632 N.E.2d 907] (1994)?”
EXHIBIT 32.1

SECTION 1350 CERTIFICATIONS

In connection with the Quarterly Report of Ruths Chris Steak
House, Inc. (the Company) on Form 10-Q for the quarter ended September 24, 2006, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Craig S. Miller, President and Chief Executive
Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:



|(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|--- | ---------------------------------------------------------------------------------------------------------------------



|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods
indicated.
|--- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

November 2, 2006



/s/ Craig S. MillerCraig S. MillerPresident and Chief Executive Officer


A signed original of this written statement required by Section 906, or other document authenticating,
acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Ruths Chris Steak House, Inc. and will be retained by
Ruths Chris Steak House, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with Amendment No. 1 to Quarterly Report on Form 10-Q/A for the period ended March 31, 2009 of (the Report) of Community Bankers Trust Corporation (the
Company), the undersigned Executive Vice President, who is acting as the Companys principal executive officer, and Executive Vice President and Chief Financial Officer certify, pursuant to 18 U.S.C. §1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that, to their knowledge:

(1) The Report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all
material respects, the consolidated financial condition and results of operations of the Company and its subsidiaries as of, and for, the periods presented in the Report.



/s/ Rex L. Smith, IIIRex L. Smith, IIIExecutive Vice President(principal executive officer)/s/ Bruce E. ThomasBruce E. ThomasExecutive Vice President and Chief Financial Officer


Date: January 13, 2011